Advisor

A Hopkins-trained internist and pathologist, Dr. Popper is Co-founder and President of Popper and Co., a consulting firm that addresses inefficiencies in health care by helping life science companies develop and commercialize new technology. Additionally, Dr. Popper is Chair of the Innovation and Commercialization Committee at JHU School of Public Health and an advisor of multiple clinical and healthcare companies.

Advisor

Dr. Rapoport is the Gary Jobson Professor of Clinical Oncology at the University of Maryland School of Medicine. An MIT and Harvard graduate, Dr. Rapoport has over 30 years of experience specializing in advanced and effective methods for cancer treatment, including autologous and allogeneic stem cell transplants and cellular immunotherapy.

Advisor

Dr. Macaya is the former ambassador of Costa Rica to the United States and is currently the Menschel Senior Leadership Fellow at Harvard T.H. Chan School of Public Health. In his former role as Executive President and Chairman of the Costa Rican Social Security, he was responsible for the provision of all public health care in Costa Rica and led the nation’s response to the COVID-19 pandemic.

Advisor

Dr. Azad is Co-Director of Cancer Genetics and Epigenetics at Johns Hopkins Hospital and directs the Developmental Therapeutics Clinical Trials Program for the Sidney Kimmel Cancer Center. Her research focuses on early-phase drug development and her clinical expertise is in cancers of the GI tract, with a concentration in CRC.

Advisor

Paul is Sr. Director of National Services and Support at Illumina. He has twenty years experience in advancing next generation sequencing for discovery of antigens or neoantigens and markers for cancer.